CS
OACCW

Clear Street’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Clear Street’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.73K Buy
9,274
+398
+4% +$335 ﹤0.01% 1224
2026
Q1 		$6.66K Hold
8,876
– – ﹤0.01% 984
2025
Q4 		$6.3K Hold
8,876
– – ﹤0.01% 811
2025
Q3 		$6.66K Hold
8,876
– – ﹤0.01% 709
2025
Q2 		$7.77K Hold
8,876
– – ﹤0.01% 529
2025
Q1 		$6.66K Buy
8,876
+7,947
+855% +$6.04K ﹤0.01% 403
2024
Q4 		$816 Buy
+929
New +$607 ﹤0.01% 500

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Clear Street's OACCW Position: Q2 2026 in Review

Clear Street increased its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 4.5% in Q2 2026, buying an estimated $335 and bringing the position to 9,274 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Clear Street first reported a position in OACCW in Q4 2024 and has held it in 7 quarters since. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • Clear Street held 9,274 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $8.73K as of Q2 2026.
  • Clear Street bought 398 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q2 2026, an estimated $335.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1224 holding.
  • Clear Street first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 7 quarters since.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.